Latest / Vanguards of Healthcare by Bloomberg Intelligence / Cortica’s Plan to Bring Value-Based Care to Autism
Transcript
- 0:21Speaker 1: Welcome to another episode of Bloomberg Intelligence's Vanguards of Healthcare podcast,
- 0:25Speaker 1: where we speak with the leaders at the forefront of
- 0:27Speaker 1: change in the healthcare industry. My name is Jonathan Palmer,
- 0:29Speaker 1: and I'm a healthcare analyst at Bloomberg Intelligence, the in
- 0:32Speaker 1: house research arm of Bloomberg. I'm thrilled to welcome doctor
- 0:36Speaker 1: Neil hat and Gatti to the program. He's the CEO
- 0:38Speaker 1: and co founder of Cordica, which was born out of
- 0:41Speaker 1: his wife and co founder, doctor Suzanne Goh's clinical practice.
- 0:45Speaker 1: Suzanne is still the company's chief medical officer. Neil brings
- 0:48Speaker 1: a really unique triple threat perspective to the table to this.
- 0:51Speaker 1: He's a Rhodes Scholar with a medical degree from Harford,
- 0:54Speaker 1: and before joining Cordica, he spent time as an equities
- 0:57Speaker 1: investor and held leadership positions at a number of medical
- 1:00Speaker 1: device companies that had successful exits. Today, he and Suzanne
- 1:04Speaker 1: are tackling one of the most fragmented and high stake
- 1:06Speaker 1: areas of medicine, autism and neurodevelopment care. Cortica is really
- 1:11Speaker 1: moving the needle by replacing siloed therapy with this integrated
- 1:14Speaker 1: whole child model that combines neurology, technology, and behavioral health.
- 1:19Speaker 1: I'm really excited to dive into how they're scaling this
- 1:21Speaker 1: model and navigating the current regulatory landscape. Neil, welcome to
- 1:25Speaker 1: the program, and thank you for joining us.
- 1:27Speaker 2: Now, thank you, Jonathan, really an honor to be here.
- 1:29Speaker 2: Thanks for that generous introduction. My pleasure.
- 1:32Speaker 1: Well, why don't we start at a very high level.
- 1:34Speaker 1: You know, what's the mission of Cordica in a few sentences.
- 1:37Speaker 2: We're really trying to defragment the clinical experience that families
- 1:42Speaker 2: would otherwise have to undergo in their diagnosis and treatment
- 1:47Speaker 2: for their child with autism or a range of neurodevelopmental conditions.
- 1:51Speaker 2: We're also trying to democratize access to the highest quality
- 1:55Speaker 2: of clinical care that would be available in the world. Typically,
- 1:59Speaker 2: this both cares only at the greatest academic centers, and
- 2:03Speaker 2: I was very fortunate along with my wife to train
- 2:05Speaker 2: at some of those places. They're outstanding. It's just very
- 2:09Speaker 2: hard to access, with long wait times and even within them,
- 2:11Speaker 2: very fragmented. So we've wanted to really democratize access to
- 2:15Speaker 2: that and defragment and coordinate what is otherwise a very
- 2:20Speaker 2: challenging and disjointed journey.
- 2:24Speaker 1: So maybe let's start with the origin of the company.
- 2:27Speaker 1: You know, as I mentioned in the intro, it's born
- 2:29Speaker 1: out of your wife's practice. But can you maybe talk
- 2:31Speaker 1: about some of the milestones as you've guys scaled it
- 2:33Speaker 1: over the last decade.
- 2:35Speaker 2: Yeah. Absolutely, So this this started with my wife's kind
- 2:40Speaker 2: of clinical passion. We met as first year medical students,
- 2:43Speaker 2: and from the first time I met her, I remember
- 2:45Speaker 2: hearing about her passion about the developing child brain and
- 2:49Speaker 2: the relationship between parents and children, particularly when children are neurodivergent.
- 2:55Speaker 2: This is back in two thousand so, well before autism
- 2:58Speaker 2: was in the the in common parlance and seen a
- 3:04Speaker 2: lot in the media, and it was very far from
- 3:06Speaker 2: my interest. To be honest, it was hard for me
- 3:09Speaker 2: to understand physiologically what was happening as a medical school student.
- 3:13Speaker 2: In fact, I learned really nothing about it. In my
- 3:16Speaker 2: time in medical school. I gravitated to where there was
- 3:19Speaker 2: kind of an easier application of technology. So like some
- 3:23Speaker 2: of like cardiology, was very straightforward for me. You could
- 3:25Speaker 2: image see illegion, you could find it either physically or
- 3:32Speaker 2: electro physiologically with things like EKG. And she continued this
- 3:37Speaker 2: passion throughout academic training, was a part of co directing
- 3:44Speaker 2: multiple academic center autism programs, and then when we had
- 3:48Speaker 2: our first kid, she wound up starting leaving academia and
- 3:52Speaker 2: starting a small boutique private practice to treat families in
- 3:55Speaker 2: this integrated way, really to get out of the encumbrances
- 4:00Speaker 2: of doing this in an academic setting. And I was
- 4:04Speaker 2: a part of three prior medtech companies helped build and transact,
- 4:10Speaker 2: And when I transacted my third I was kind of
- 4:12Speaker 2: looking for my next thing to do, and had historically
- 4:16Speaker 2: spent time in fields like cardiology and anti surgery, and
- 4:20Speaker 2: was just fascinated by the kind of clinical outcome she
- 4:22Speaker 2: was getting and how desperately needed this kind of innovation
- 4:26Speaker 2: was in autism care. Compared to cardiology, where there's a
- 4:29Speaker 2: lot of innovation, there are fifty some startups pursuing individual
- 4:35Speaker 2: therapeutic indications and autism, there are very few that are
- 4:38Speaker 2: really like pushing the needle, certainly at that time, which
- 4:41Speaker 2: is back in like twenty sixteen or so, about ten
- 4:43Speaker 2: years ago. So I joined with the intent of taking
- 4:48Speaker 2: a model that had been well validated and shown to
- 4:51Speaker 2: be very effective at that time, maybe fifty sixty families
- 4:56Speaker 2: not really being able to take insurance, not being able
- 4:59Speaker 2: to scale that time. And my goal here was to
- 5:03Speaker 2: work with her to scale, make it more accessible, join
- 5:08Speaker 2: with health plans, build the underlying technology infrastructure. How are
- 5:12Speaker 2: we going to hire multi disciplinary care teams and train
- 5:15Speaker 2: them to work together. So key milestones for us were
- 5:19Speaker 2: really about first being able to demonstrate that what she
- 5:25Speaker 2: was doing on her own as a single physician working
- 5:28Speaker 2: with the small team could be scaled beyond her. So
- 5:32Speaker 2: could we bring in other physicians of different specialties and
- 5:36Speaker 2: trainer to train them to deliver that same level of effectiveness.
- 5:41Speaker 2: Then it was about can we build an underlying technology
- 5:44Speaker 2: platform that allows this group of clinicians to work together,
- 5:50Speaker 2: because there's no off the shelf electronic medical record that
- 5:53Speaker 2: combines everything on the medical side, So you're ordering MRIs
- 5:57Speaker 2: and labs and prescribing medication to what is done in
- 6:01Speaker 2: ABA applied behavioral analysis. That is a lot of field work,
- 6:05Speaker 2: it's a lot of data collection. Those EMRs could not
- 6:07Speaker 2: be more different, and so how can you kind of
- 6:10Speaker 2: put those together make the data from both sides accessible
- 6:14Speaker 2: to clinicians from both sides. That was a big milestone,
- 6:19Speaker 2: and I'll say sort of four In total, those are two.
- 6:23Speaker 2: A third is around can we scale from more than
- 6:25Speaker 2: one location? For a long time we only in one place?
- 6:30Speaker 2: And then the fourth was attracting capital. Could this get
- 6:33Speaker 2: to a place where outside investors would say, hey, this
- 6:36Speaker 2: is outside the norm of standard odds and therapy, which
- 6:40Speaker 2: at the time was applied behavioral analysis. But could we
- 6:43Speaker 2: get professional investors and at ideally strategic investors who represented
- 6:49Speaker 2: health plans, parent groups to buy into this model and
- 6:53Speaker 2: help scale it. So those are the milestone we sort
- 6:55Speaker 2: of saw between say twenty sixteen and twenty twenty that
- 6:59Speaker 2: really allowed to start to grow.
- 7:02Speaker 1: That was a great summary, you know, maybe taking it
- 7:04Speaker 1: a step deeper, you talked about the quartica model and
- 7:07Speaker 1: maybe the traditional model. Can you maybe further bifurcate the
- 7:10Speaker 1: difference between those two and how maybe Cordica's model of
- 7:14Speaker 1: treatment is different than the traditional ABA.
- 7:18Speaker 2: Yeah, the traditional model of applied be hero analysis ABA
- 7:22Speaker 2: has tremendous great data going back twenty thirty years. It
- 7:27Speaker 2: is founded in psychology, great outcomes data spanning dozens and
- 7:34Speaker 2: dozens of publications, and autism speaks and other industry groups. Really,
- 7:41Speaker 2: parent advocacy groups were very successful over the past twenty
- 7:45Speaker 2: years in getting ABA covered at the state level and
- 7:49Speaker 2: a lot of bipartisan federal support, which was a huge
- 7:53Speaker 2: win for the field. ABA relies on behavioral modification for children,
- 7:59Speaker 2: so it's about positive and negative reinforcements, understanding what causes
- 8:05Speaker 2: a child to behave in an optimal way and what
- 8:09Speaker 2: causes a child to behave in dysregulated or self injurious ways,
- 8:15Speaker 2: and how do you reinforce when they're behaving appropriately versus not.
- 8:20Speaker 2: It's a really important tool, and the issue that we
- 8:25Speaker 2: have had as physicians is it should be one of
- 8:28Speaker 2: several tools that are employed, just like every other field
- 8:31Speaker 2: of medicine. I spend a lot of time in cardiology
- 8:33Speaker 2: and specifically interventional cardiology, which is a wonderful tool. There
- 8:36Speaker 2: are lots of innovation incenting and plaque excision and things,
- 8:42Speaker 2: but we always knew that it was one of many tools.
- 8:44Speaker 2: I mean, you want to actually avoid the need for
- 8:47Speaker 2: interventional procedures by being preventive on the front end, and
- 8:50Speaker 2: then there's a category of lesions where you need surgery
- 8:52Speaker 2: and intervention is inappropriate. So similarly, in autism, a BA
- 8:57Speaker 2: is a very important tool, but it should sit alongside
- 9:01Speaker 2: a thoroughmedical understanding of each child, and that's about understanding
- 9:06Speaker 2: their genetic underlying conditions. Are their metabolic issues that are
- 9:11Speaker 2: that are happening, so mitochondrial dysfunction, vitamin deficiencies, immune dysregulation,
- 9:16Speaker 2: microbiome dysfunction, all of these have been very well characterized
- 9:21Speaker 2: and understood in the neurology, developmental, pediatrics, and fields. There's
- 9:26Speaker 2: a lot around seizure management. Twenty to thirty percent of
- 9:28Speaker 2: children with autism have underlying seizure disorders if those aren't treated,
- 9:35Speaker 2: and sometimes in the worst case, you'll see a child
- 9:37Speaker 2: who has issues of seizure, but they are seen in
- 9:41Speaker 2: the ABA field for very valid reasons as self simulatory
- 9:46Speaker 2: behaviors and treated with behavioral modification, whereas really it's a
- 9:49Speaker 2: seizure that needs to be treated with appropriate ketogenic diet,
- 9:54Speaker 2: the right medication management. There's a lot around feeding, making
- 9:59Speaker 2: sure children are eating the right foods that then lead
- 10:02Speaker 2: to the right GI health throughout a lot around sleep,
- 10:06Speaker 2: medication management for conditions like ADHD, and then their developmental
- 10:11Speaker 2: goals around sensory processing, fine and gross motor skills that
- 10:15Speaker 2: are addressed by things like speech therapy, occupational therapy, and
- 10:19Speaker 2: then overall child and family wellness, which are addressed by psychotherapy, counseling,
- 10:25Speaker 2: social workers, and so we deeply believe, I deeply believe
- 10:30Speaker 2: that ABA is very, very important. It's a huge part
- 10:33Speaker 2: of the toolkit in working with children and their families.
- 10:37Speaker 2: It's just not complete on its own, in the same
- 10:41Speaker 2: way that every other field of medicine wouldn't view a
- 10:44Speaker 2: single tool, though highly effective, to be complete on its own.
- 10:48Speaker 2: And Cordica differs from kind of conventional ABA therapy where
- 10:53Speaker 2: we say this is really important, but it is a
- 10:55Speaker 2: part of what we do. It's the largest single part
- 10:57Speaker 2: of our workforce. We have about twenty two hundred employees,
- 11:00Speaker 2: half of them are in a BA even more, but
- 11:05Speaker 2: we complement them with all the other services that are required,
- 11:08Speaker 2: similar to what's done in academic medical centers where they
- 11:11Speaker 2: really try to bring together a holistic evaluation, a multidisciplinary evaluation,
- 11:15Speaker 2: and use that to come up with a multidisciplinary treatment plan.
- 11:20Speaker 1: So do all those services sit or are those different
- 11:22Speaker 1: services sit under Cordica's roof for Umbrella today, they do, Yeah,
- 11:26Speaker 1: they do.
- 11:28Speaker 2: We've figured out over the years on how to deliver
- 11:32Speaker 2: all those services with the fewest number of clinician types
- 11:36Speaker 2: and so it's only about a half dozen or so.
- 11:39Speaker 2: But our physicians and nurse practitioners are very versatile. We
- 11:44Speaker 2: train them to be. They're well rounded clinicians in being
- 11:49Speaker 2: able to work up where appropriate genetic issues, metabolic issues, sleep.
- 11:56Speaker 2: We have experts within quartica who specialize in things like
- 11:59Speaker 2: epileps neurogenetics or medication management s peciiclarly in this field
- 12:04Speaker 2: called psychopharmacology. But the physicians at each center or the
- 12:08Speaker 2: nurse practitioners that each center really functions as generalists. And similarly,
- 12:13Speaker 2: we have bcbasports certified behaviors who do a BA but
- 12:18Speaker 2: are really thoughtful about how are these other symptoms signs arising?
- 12:23Speaker 2: How can I coordinate with this internal care team around me.
- 12:28Speaker 2: So though we treat a lot, it's done by kind
- 12:31Speaker 2: of the smallest group we can, which is about a
- 12:34Speaker 2: half dozen clinician types.
- 12:37Speaker 1: So you mentioned it briefly there, but how does care
- 12:40Speaker 1: coordination work? Is it by the physician or those BCBAs
- 12:44Speaker 1: or a combination thereof.
- 12:46Speaker 2: It's a combination. We have a couple of roles that
- 12:50Speaker 2: are really dedicated to their administrative roles that are really
- 12:53Speaker 2: dedicated to care coordination. So on the initial stages, it's
- 12:56Speaker 2: an intake coordinator who helps guide the parents to the
- 13:00Speaker 2: right the evaluation and work up, depending on how much
- 13:03Speaker 2: diagnostic information they have before they arrive. Then it's a
- 13:08Speaker 2: medical assistant in the early days, as the medical workup
- 13:12Speaker 2: is being done and various tests are being ordered. We
- 13:16Speaker 2: don't do all the testing in house. We do genetic testing,
- 13:19Speaker 2: we do EEGs, but we don't do labs. For example,
- 13:22Speaker 2: we don't like blood draws in our clinics, so the
- 13:24Speaker 2: medical assystem will facilitate that, often with sometimes outside academic
- 13:28Speaker 2: centers or lab facilities. And then we have a scheduling
- 13:32Speaker 2: care coordinator. Once that comprehensive treatment plan is developed. That
- 13:37Speaker 2: scheduling care corder make sure that every type of service
- 13:41Speaker 2: that that family needs is available to them in the
- 13:46Speaker 2: right site of service, in the sense that some of
- 13:49Speaker 2: those are best delivered in the home because it most
- 13:51Speaker 2: generalizes the type of therapy. A clinic is a much
- 13:55Speaker 2: more constrained and fixed environment where you're most likely to
- 13:58Speaker 2: get good results, which is great. At some point you
- 14:00Speaker 2: want to fade that into the home. Some of our
- 14:02Speaker 2: services can be done by telehealth, particularly when they're parent facing,
- 14:06Speaker 2: not working with the child but only with the parents,
- 14:08Speaker 2: and so this care coordinator make sure that all the
- 14:11Speaker 2: different components of care are available to the family at
- 14:15Speaker 2: the right time, at the right side of service by
- 14:17Speaker 2: the right clinician. We do struggle with weightless with some
- 14:21Speaker 2: of these things, particularly like primetime hours. A lot of
- 14:24Speaker 2: the after school hours are hard to come by, so
- 14:28Speaker 2: they kind of manage the wait list as well. So
- 14:31Speaker 2: we have those administrative roles, and we also have the
- 14:34Speaker 2: clinicians themselves doing care coordination via rounds, so we have
- 14:40Speaker 2: every week a dedicated time where the whole team comes together.
- 14:44Speaker 2: It's very similar to what's done in academia at rounds
- 14:48Speaker 2: or tumor board is another way people kind of think
- 14:51Speaker 2: about this, where you bring multiple experts together, you have
- 14:54Speaker 2: fifteen cases to review and it's a fascinating exchange where
- 14:58Speaker 2: a clinician behavior technician who's working with the child in
- 15:02Speaker 2: the home may say, I noticed the child's getting really
- 15:05Speaker 2: groggy around three pm. What have we done with as medications?
- 15:09Speaker 2: And the physician can adjust the dosage or notice the
- 15:13Speaker 2: child's really disregulated around these times. How do we improve
- 15:16Speaker 2: the AAC which is alternative or augmentative communication device, so
- 15:20Speaker 2: they're able to better communicate and therefore back down on
- 15:24Speaker 2: some behaviors. So it's a very collaborative, cool environment where
- 15:28Speaker 2: our care coordination really flourishes.
- 15:31Speaker 1: God, the complexity you just described there. I'm thinking of
- 15:33Speaker 1: a family who doesn't have this, this opportunity to work
- 15:37Speaker 1: with the care coordinator, trying to do it all by themselves.
- 15:40Speaker 1: It must be a full time job.
- 15:43Speaker 2: Yeah, you said it perfectly. You know what made me
- 15:45Speaker 2: get into the field, and you mentioned my background. I
- 15:49Speaker 2: was a securities analyst on the buy side, trying to
- 15:53Speaker 2: figure out, like you know, whether markets or individual kind
- 15:57Speaker 2: of areas of healthcare were worth pursuing. And when I
- 16:00Speaker 2: spoke to ten families to understand is this venture and
- 16:05Speaker 2: autism a worthy one? I heard exactly what you said
- 16:08Speaker 2: ten times. It was. The common story is, you know,
- 16:12Speaker 2: the two parent working household. One of the two parents
- 16:14Speaker 2: leaves the workforce to do all this quarterbacking. It is
- 16:18Speaker 2: a challenge. And in the old days, they used to
- 16:20Speaker 2: keep a binder where they would have the medical records
- 16:23Speaker 2: from the diagnosing psychologist. Give that to the pediatrician. The
- 16:27Speaker 2: pediatricians say, hey, go to a GI specialist. They would
- 16:30Speaker 2: then get that work up, they would hand that to
- 16:32Speaker 2: their ABA team, and so it really is a full
- 16:35Speaker 2: time job quarterbacking it. And parents have to get very
- 16:39Speaker 2: very smart about what works, what doesn't work, And for
- 16:43Speaker 2: their own child, they are a lot of data capture. Hey,
- 16:49Speaker 2: when we expose our child of these things, these good
- 16:51Speaker 2: things happen or these bad things happen. So they're constantly
- 16:54Speaker 2: taking data and figuring out correlations and presenting that back
- 16:58Speaker 2: to their clinical team. It is very, very difficult. And
- 17:01Speaker 2: what shocked me is you take a condition like oncology,
- 17:04Speaker 2: which is and it's a very scary and challenging condition.
- 17:09Speaker 2: If we expected patients to navigate between surgery, medication, radiation,
- 17:15Speaker 2: and that whole pathway themselves, it would just be I
- 17:19Speaker 2: mean that that would make no sense. The algorithm is
- 17:23Speaker 2: that you get imaging work up, biopsy, genetic workup, and
- 17:28Speaker 2: based on that you're put into a workflow. And the
- 17:31Speaker 2: patient's job is to recover and heal and focus on
- 17:35Speaker 2: getting better as opposed to deciding what should I be
- 17:39Speaker 2: getting at what time? Is now the right time for
- 17:41Speaker 2: me to get surgery or It's just it's crazy to
- 17:44Speaker 2: think that that would be the expectation in cancer care,
- 17:48Speaker 2: yet we expect that of families and autism, and so
- 17:53Speaker 2: that's why we built we built the company. It just
- 17:55Speaker 2: feels felt like at some point in the future, near future,
- 17:58Speaker 2: I think we'll look back and say, it just very
- 18:00Speaker 2: unreasonable to expect parents to be parents and guide their
- 18:04Speaker 2: their children through through such a fragmented ecosystem.
- 18:07Speaker 1: Well, that's a it's funny. I was just thinking about
- 18:09Speaker 1: the word ecosystem for my next question, how to how
- 18:12Speaker 1: do patients and families enter the CORDICAI ecosystem? You know, where,
- 18:16Speaker 1: where were where were they? And how do they wind
- 18:18Speaker 1: up on your doorstep?
- 18:21Speaker 2: A lot of them find uh, find us themselves. This
- 18:25Speaker 2: is a very active group that are trying to define
- 18:28Speaker 2: the right therapies for them. And they come either pre diagnosis,
- 18:33Speaker 2: like they've noticed a a challenge in meeting developmental milestones,
- 18:40Speaker 2: or a preschool teacher, their pediatrician may have said something
- 18:43Speaker 2: to them and they're trying to find the right the
- 18:46Speaker 2: right next step, or sometimes it's they have been in
- 18:50Speaker 2: the system, ping ponging between say lots of A B A.
- 18:54Speaker 2: They've been an academic center, ping pong between different medical
- 18:57Speaker 2: providers and the child is ten, twelve, fourteen, and they're
- 19:02Speaker 2: continuing to observe challenges, and so they find us that way.
- 19:06Speaker 2: That's a good chunk. Maybe half of our patients just
- 19:09Speaker 2: they themselves kind of find us through word of mouth
- 19:12Speaker 2: or online searches, just you know, the communities they're a
- 19:16Speaker 2: part of. We also get a lot of referrals from
- 19:20Speaker 2: primary care pediatricians, So PCPs in pediatrics are used to
- 19:27Speaker 2: having a roster of developmental pediatrician specialists or pediatic neurologists
- 19:32Speaker 2: to refer a whole range of conditions. So autism is
- 19:36Speaker 2: about half of what we see, but the other half
- 19:38Speaker 2: is a whole range of developmental neurologic conditions, everything from ADHD, headache, seizure,
- 19:46Speaker 2: down syndrome, rare genetic syndromes, speech delay, motor delay. And
- 19:52Speaker 2: so we like to be thought of for those primary
- 19:55Speaker 2: care pediatricians as a trusted referral source for anything develop
- 20:00Speaker 2: mental neurologic. They don't have to work up the odds
- 20:02Speaker 2: and they don't have to think it's anything that they
- 20:05Speaker 2: would feel like we could be helpful. We encourage them
- 20:09Speaker 2: to send it's hard to be a primary care pediatrician,
- 20:12Speaker 2: you see lots of stuff coming your way. I mean
- 20:14Speaker 2: it's infectious things, orthopedic things, developmental things, psychiatric, and so
- 20:21Speaker 2: we like to say, have the maybe twenty five percent
- 20:24Speaker 2: that you see that falls under kind of neurodevelopment, send
- 20:27Speaker 2: them to us and we'd love to help. And we
- 20:29Speaker 2: have this feedback loop between a specialist physician and the
- 20:32Speaker 2: PCP to show them you post that referral, how is
- 20:36Speaker 2: the child doing in our hands? Those are the primary too.
- 20:40Speaker 2: We are starting to get some collaboration with health plans
- 20:44Speaker 2: where health plans have done the work of claims analysis
- 20:49Speaker 2: and found that this holistic model saves them a lot
- 20:51Speaker 2: of money compared to I can go through kind of
- 20:54Speaker 2: the components of savings, but they found that as fifty
- 20:58Speaker 2: to sixty percent savings per member per year basis. So
- 21:02Speaker 2: they are increasingly sending members to us. But parents don't
- 21:07Speaker 2: always use their health plan uh to find resources I
- 21:10Speaker 2: could see, So it's own. Yeah, it's only one pair,
- 21:12Speaker 2: and health plans are kind of made aware of these
- 21:14Speaker 2: situations they send them to us. So it's probably no
- 21:16Speaker 2: more than ten to twenty percent of our of our
- 21:18Speaker 2: intake today is through that channel.
- 21:21Speaker 1: Well, I think we'll come back maybe to the numbers
- 21:24Speaker 1: and the finances and the payments, but just thinking about
- 21:26Speaker 1: your footprint and your scale. What states are you guys
- 21:29Speaker 1: in today and where do you aspire to be And
- 21:32Speaker 1: I don't know the next three to five years.
- 21:36Speaker 2: We're in eight states today, so kind of west coast, Midwest, Northeast,
- 21:42Speaker 2: in North Carolina, in the South. And the pattern has
- 21:47Speaker 2: been when we left, we started in California, so that's
- 21:51Speaker 2: our largest footprint, it's about forty percent of our center.
- 21:54Speaker 2: Is the starting to decrease as a percentage of the total.
- 21:59Speaker 2: And then as we expanded across the country. It was
- 22:02Speaker 2: kind of for two reasons. One is we found a
- 22:04Speaker 2: physician who was very like minded, similar profile to my
- 22:09Speaker 2: co founder and wife Suzanne, to ped atronologists, developmental pediatrician
- 22:14Speaker 2: who was practicing in say academia or a multi physician group,
- 22:19Speaker 2: saying that, Hey, it's really challenging for me to see
- 22:22Speaker 2: these families do a work up and then not being
- 22:26Speaker 2: able to really engage in that follow through. I said,
- 22:29Speaker 2: referrals out for aba OTPT for school care. I sent
- 22:34Speaker 2: them to other specialists and some percent of the time
- 22:37Speaker 2: they're able to make that happen. They come back there successful,
- 22:40Speaker 2: but the vast majority of the time they're not, and
- 22:43Speaker 2: I only hear of the feedback when the parent comes back,
- 22:45Speaker 2: and it's very difficult for me to really make the
- 22:50Speaker 2: kind of gains that I'd like. And so we had
- 22:52Speaker 2: physicians across the country reach out to us in Texas,
- 22:56Speaker 2: in New Jersey, in areas. So those were kind of
- 23:02Speaker 2: reasons we entered those states. Illinois very physician driven, and
- 23:07Speaker 2: then we would build around those physicians this interdisciplinary care team.
- 23:12Speaker 2: The other way that we started to expand was with
- 23:14Speaker 2: health plans. As we got to know more health plans,
- 23:18Speaker 2: they were saying, we see this problem of fragmentation for
- 23:21Speaker 2: our members, this provider ecosystem where we're seeing for a
- 23:24Speaker 2: given member, claims coming in from fifteen different providers and
- 23:27Speaker 2: look like anyone is talking to each other. See a
- 23:29Speaker 2: lot of overutilization from those inductal provider application. I'm sure
- 23:33Speaker 2: a lot of duplication. Absolutely, medication is overused because a
- 23:40Speaker 2: physician doesn't see that they're also getting other therapies somewhere else.
- 23:43Speaker 2: And so in multiple instances, we were pulled into states
- 23:48Speaker 2: by health plans. So Massachusetts, North Carolina were places where
- 23:53Speaker 2: it was really about the plans pulling us in Arizona.
- 23:57Speaker 2: Now we had a small footprint. We're massively expanding because
- 24:00Speaker 2: of large health plan collaborations, and I think that will
- 24:04Speaker 2: be our future. We are only now expanding where health
- 24:08Speaker 2: plans are saying, hey, this makes a lot of sense.
- 24:11Speaker 2: We're going to construct a novel incentive system value based care,
- 24:17Speaker 2: and specifically in value based care, it's a whole child,
- 24:19Speaker 2: whole person, value based care where we integrate medical and
- 24:22Speaker 2: behavioral and reward coordination of care, reward permember per year
- 24:29Speaker 2: savings versus the conventional fee for service model. And we're
- 24:33Speaker 2: seeing receptivity across the country. I mean there's no plan
- 24:36Speaker 2: we talk to that says, yeah, this makes no sense.
- 24:39Speaker 2: Every plan, every plan does this in so many areas
- 24:43Speaker 2: like kind of kidney disease and diabetes and heart failure
- 24:47Speaker 2: and orthopedics. I mean, the movement is to integration, coordination,
- 24:52Speaker 2: paying for value, paying for quality, and so it's really
- 24:56Speaker 2: about a plan's kind of infrastructure capabilities to pull this off.
- 25:03Speaker 2: And so our hope is over the next three to
- 25:05Speaker 2: five years, we are in most major metro areas across
- 25:09Speaker 2: the country and also have a virtual version of our
- 25:14Speaker 2: program in all fifty states, and that's actively in development.
- 25:18Speaker 2: We have that virtual version in all the eight states
- 25:20Speaker 2: we operate in today, so you could anywhere in the
- 25:22Speaker 2: state of Massachusetts or anywhere in state of California and
- 25:25Speaker 2: access us virtually. We're looking to expand that that footprint,
- 25:29Speaker 2: and it really comes from this this ethos. Why I
- 25:33Speaker 2: feel compelled to expand is I've heard too many parent
- 25:37Speaker 2: stories from parents and states we don't operate in countries
- 25:41Speaker 2: we're not in of how challenging the journey is otherwise,
- 25:45Speaker 2: like they'll hear from the FDA, you know six months ago,
- 25:48Speaker 2: luc of orn is the panacea that you should be
- 25:52Speaker 2: thinking about. I don't think they quite said that, but
- 25:54Speaker 2: that was the misinterpretation. And so parents everywhere are like, hey,
- 25:58Speaker 2: should this be a part of my child's program? And
- 26:01Speaker 2: if you don't have expert physicians to say, this is
- 26:04Speaker 2: really about fully metabolism, which needs to be studied the
- 26:06Speaker 2: right way for your child, and if so, then it's appropriate.
- 26:09Speaker 2: If not, it shouldn't be used. But that stuff happens
- 26:12Speaker 2: all the time with like should my child be diagnosed
- 26:14Speaker 2: with ADHD and on a stimulant? Should we be thinking
- 26:18Speaker 2: about nutrition differently? And get lab work ups are they
- 26:22Speaker 2: do have a mitochondrial difficially, it's very common in this
- 26:25Speaker 2: patient population. Being able to solve those problems at scale
- 26:29Speaker 2: for parents around the country is really a kind of
- 26:32Speaker 2: underlying driving force for me and our team.
- 26:36Speaker 1: Maybe just going back to one thing you mentioned around payers,
- 26:39Speaker 1: what does the mix like look like between government and
- 26:44Speaker 1: private commercial pay.
- 26:46Speaker 2: We're about seventy five twenty five now. We were seventy
- 26:50Speaker 2: five commercial and twenty five Medicaid. And within that Medicaid
- 26:56Speaker 2: it's mostly managed Medicaid, so we do very little with
- 26:59Speaker 2: state directly. We mostly work with managed care intermediaries. That
- 27:05Speaker 2: Medicaid side is rapidly growing for us because in the
- 27:09Speaker 2: past twelve months, more and more plans and state governments
- 27:15Speaker 2: have realized that this is a massively growing spend item
- 27:19Speaker 2: which we may get to. But it's been the public
- 27:21Speaker 2: the topic of multiple articles over the past several months,
- 27:26Speaker 2: and a lot of questions of like what's the right
- 27:28Speaker 2: way to balance their fiscal responsibility with taking care of
- 27:33Speaker 2: families that we owe you we have an obligation to.
- 27:36Speaker 2: But we're seeing that medicaid side of our business grow
- 27:39Speaker 2: rapidly because they're looking for a solution that best manages
- 27:43Speaker 2: the needs of families with the right financial way to
- 27:47Speaker 2: do it.
- 27:48Speaker 1: Well, let's talk about that kerfuffle and the media. You know,
- 27:52Speaker 1: there was the Wall Street Journal article about Indiana and
- 27:54Speaker 1: some of the bad actors on the medicaid side. And
- 27:58Speaker 1: I guess, what's what's your perspective on on maybe that
- 28:02Speaker 1: article and the issue And then you know, I think
- 28:04Speaker 1: that maybe the secondary question is around the challenge between
- 28:08Speaker 1: fee for service incentivizing things versus you know, value based care.
- 28:13Speaker 1: I think maybe if you cover both those buckets, we
- 28:16Speaker 1: we wand up in the same and an interesting spot.
- 28:19Speaker 2: Yeah, they're super related. And it's a really good question
- 28:23Speaker 2: and insight of yours that that it's the second issue
- 28:27Speaker 2: fee for service and incentives around it that drives the first.
- 28:31Speaker 2: So that the the articles did a really nice job
- 28:33Speaker 2: of highlighting some real challenges. I mean some are outright
- 28:37Speaker 2: fraud and true abuse. So and there have been stories
- 28:43Speaker 2: in Minnesota where where companies are fabricating actually the delivery
- 28:49Speaker 2: of services, paying families to say that they were in
- 28:53Speaker 2: receipt of services. That's obviously outright fraud. The Indiana story
- 28:58Speaker 2: spoke about, you know, a company that realized that they
- 29:02Speaker 2: were just getting paid a percent of their build rate,
- 29:05Speaker 2: no matter what that build rate was. And so went
- 29:07Speaker 2: from you know, reasonable one hundred dollars an hour for
- 29:12Speaker 2: for for deliver for care delivered to three hundred dollars
- 29:15Speaker 2: to six hundred dollars and up and up and up,
- 29:17Speaker 2: and that's that's clearly like just abusing a system. I
- 29:21Speaker 2: think that's the minority, truly, the minority of cases, Like
- 29:25Speaker 2: it's a one to two percent issue. The ninety eight
- 29:29Speaker 2: percent issue is over utilization, which is kind of what
- 29:33Speaker 2: I started this conversation with. We approached it clinically. We
- 29:38Speaker 2: just didn't feel like as physicians, every child needed lots
- 29:42Speaker 2: and lots of ABA. It should be part of an
- 29:45Speaker 2: overall care plan. It should be dosed based on the
- 29:48Speaker 2: needs of that child and compared to all their other needs.
- 29:52Speaker 2: Like if the major issues around GI health and metabolic
- 29:57Speaker 2: workup and mitochondrial supplements and they're seizure issues, sleep issues
- 30:03Speaker 2: like that needs to be attended taken care of in
- 30:06Speaker 2: the context and an ABA program that's that's dosed appropriately.
- 30:09Speaker 2: So we were thinking about it purely clinically. But the
- 30:13Speaker 2: consequence of that on the economic side is then you
- 30:16Speaker 2: need a lot less A B A. And so what
- 30:20Speaker 2: has happened to drive up spend is it's been rampantly
- 30:25Speaker 2: over utilized and indiscriminately. I think there are children who
- 30:31Speaker 2: certainly need that level, but there are many children who don't,
- 30:35Speaker 2: and that's been kind of the root cause of the
- 30:39Speaker 2: of the problem. In the journals articles, that's talking about
- 30:42Speaker 2: a four x increase and spend for more most states
- 30:45Speaker 2: over the past three years, and that's four hundred percent
- 30:48Speaker 2: in three years. Is very difficult for any state budget
- 30:51Speaker 2: to sustain. To your second question, that it ties to
- 30:56Speaker 2: that perfectly, and that if the system incentivizes via a
- 31:00Speaker 2: fee for service structure, that is, you only get paid
- 31:03Speaker 2: for every hour you bill, then of course as a provider,
- 31:08Speaker 2: you are incentivized to build the most number of hours.
- 31:12Speaker 2: And if the response of health plans or states to
- 31:16Speaker 2: that is to cut the rate and say, hey, we're
- 31:18Speaker 2: paying X and now should pay eight percent of X,
- 31:22Speaker 2: it drives the behavior in the wrong direction, which is
- 31:25Speaker 2: the provider saying, hey, for me to be sustainable, I
- 31:29Speaker 2: now have to build twenty five percent more than it
- 31:33Speaker 2: was before in volume. So it's just like downward spiral.
- 31:37Speaker 2: It also leads to a downward spiral and talent. If
- 31:39Speaker 2: you're getting paid eighty percent less per hour, it's like, well,
- 31:42Speaker 2: I can't hire the experienced clinicians who demand a higher salary.
- 31:48Speaker 2: You're committed to the field for years. I got to
- 31:50Speaker 2: hire the dabbler who is new to the field and
- 31:53Speaker 2: may only last six months or a year, but they're
- 31:56Speaker 2: taking this on at a sub market wage. That downward
- 32:02Speaker 2: spiral is awful because it reads leads to real negative
- 32:05Speaker 2: clinical consequences for families. The only way to fix this
- 32:11Speaker 2: is to change the incentive structure, which is you have
- 32:14Speaker 2: to reward value, and you have to reward holistic value.
- 32:19Speaker 2: That is not just behavioral outcomes that would be treated
- 32:23Speaker 2: with ABA. You've got to reward all the outcomes that
- 32:26Speaker 2: parents would care about, which is sleep and feeding and
- 32:30Speaker 2: all the things that parents come forward with with a
- 32:32Speaker 2: young child. And then as that child ages, reward getting
- 32:37Speaker 2: them into school, successfully supporting them while they're in school,
- 32:41Speaker 2: and over a lifetime, getting them into college, getting them
- 32:45Speaker 2: appropriate vocational training with the right job, getting them into
- 32:48Speaker 2: independent living. All those things matter as opposed to the
- 32:52Speaker 2: current system, which heavily incentivizes lots of ABA at a
- 32:56Speaker 2: young age and then fades away support as the as
- 33:00Speaker 2: the child ages into into adolescents and into adulthood. So
- 33:06Speaker 2: it's very fixable because you just have to know what's
- 33:11Speaker 2: very easy to know what to families and children and
- 33:15Speaker 2: adults with autism need and reward those things and then
- 33:20Speaker 2: allow the provider ecosystem to respond to those incentives. This
- 33:25Speaker 2: should not be a a tie rate against private equity
- 33:30Speaker 2: and healthcare because that's an easy thing to do. It's
- 33:34Speaker 2: it's actually more about private equity's driven a lot of capital,
- 33:36Speaker 2: Whi's driven a lot of access, which has been good
- 33:39Speaker 2: for the field. Actually more centers, more availability. I think
- 33:43Speaker 2: it's gotten more therapists into into the field. What's broken
- 33:46Speaker 2: is the incentive system. And if you fix the incentive system,
- 33:50Speaker 2: that capital will will be attracted to the right kinds
- 33:54Speaker 2: of outcomes. And I would encourage more capital here because
- 33:58Speaker 2: it's still dwarfed by the fields I came from, like
- 34:01Speaker 2: cardiology on college. It's nothing compared compared to those fields,
- 34:05Speaker 2: and we need more. So this is not an anti
- 34:07Speaker 2: private equity or growth equity in those things. It's it's
- 34:11Speaker 2: about fixing the incentive so that capital will be put
- 34:13Speaker 2: to work in the right ways.
- 34:15Speaker 1: Well, maybe we'll come back to the capital discussion. You know,
- 34:19Speaker 1: I'll put my finance happ back on in a couple
- 34:21Speaker 1: of minutes. But thinking about the incentive structure, I mean,
- 34:24Speaker 1: if you could change one thing today, or ask Washington
- 34:27Speaker 1: to change one thing today, what would it be.
- 34:29Speaker 2: It's it's payment for value, payment for value. That that
- 34:34Speaker 2: word has been kind of it's been used a lot
- 34:37Speaker 2: in the past ten years. Is the panacea value based care?
- 34:40Speaker 2: It was big initiatives out of the CMMI, which is
- 34:43Speaker 2: innovation inside of CMS. And I think because of something's
- 34:48Speaker 2: gone wrong around providers taking risk, that risk not being
- 34:55Speaker 2: calibrated properly, either being over awarded or underrewarded for it.
- 34:58Speaker 2: It's kind of I think folks have said it's not
- 35:02Speaker 2: the panacee era. It may be like even a bad word,
- 35:05Speaker 2: but in this context of autism, when you compare fee
- 35:08Speaker 2: for service, where providers are rewarded today for driving as
- 35:12Speaker 2: much volume as they can, a pivot to saying hey,
- 35:16Speaker 2: we're going to pay for the outcomes that matter to families,
- 35:20Speaker 2: just value based care. That that is a single biggest
- 35:22Speaker 2: thing that and the federal government doesn't really control that
- 35:26Speaker 2: much in policy, but what they can do is issue
- 35:29Speaker 2: guidance statements and encourage states commercial health plans, manage Medicaid
- 35:35Speaker 2: organizations to pay for value. That's the single biggest thing
- 35:40Speaker 2: that the field could really use.
- 35:43Speaker 1: Maybe switching back to that capital discussion, you guys raised
- 35:46Speaker 1: some capital back in twenty twenty four. I believe that
- 35:49Speaker 1: was your last round. What did you guys earmark that for?
- 35:52Speaker 1: And I guess you know what are your capital needs today?
- 35:56Speaker 1: And sitting here at the start of twenty twenty six.
- 35:59Speaker 2: Yeah, we've been fortunate in raising sort of every eighteen
- 36:05Speaker 2: to twenty four months starting back in twenty nineteen, and
- 36:07Speaker 2: so did a Series D extension last year that was strategic.
- 36:11Speaker 2: We had a large family office with a connection to
- 36:13Speaker 2: autism come in and then Morgan Health which is JP
- 36:16Speaker 2: Morgan's healthcare innovation arm. And in all cases the use
- 36:21Speaker 2: of proceeds has been kind of similar. It's infrastructure building
- 36:25Speaker 2: a lot around technology. We have a very large tech
- 36:28Speaker 2: team that's done a lot smaller with AI, but it's
- 36:32Speaker 2: really enabled us to do all the care coordination, all
- 36:34Speaker 2: the complex data storage across all these different sources. But
- 36:41Speaker 2: tech is one area. Also, infrastructure around learning and development, hiring,
- 36:48Speaker 2: clinical quality publications were one of the few in the
- 36:51Speaker 2: field that puts out academic medical center type publications every
- 36:56Speaker 2: year or so. So that's been one purpose and the other
- 37:00Speaker 2: has been expansion. So uh, as we expand the new states,
- 37:04Speaker 2: the capital we put in before those sites become profitable.
- 37:08Speaker 2: In terms of future capital needs, we're we're very close
- 37:11Speaker 2: to the point of operating sustainably. We we raised a
- 37:16Speaker 2: fair bit of capital over our you know a through
- 37:20Speaker 2: d uh, and so really an imperative that that our
- 37:23Speaker 2: leadership team is set for ourselves is use this capital
- 37:27Speaker 2: to operate sustainably. We may go out to the markets
- 37:30Speaker 2: again you sometime end of this year, early next year,
- 37:34Speaker 2: but it will be growth beyond our existing footprint, not
- 37:38Speaker 2: to uh, not not to fund the cash burn of
- 37:43Speaker 2: the business, but really around kind of that next phase
- 37:45Speaker 2: of explosive growth. As we more and more see this
- 37:50Speaker 2: whole child, whole person care model become increasingly the standard
- 37:55Speaker 2: of care.
- 37:56Speaker 1: When you scale and and you know, go to a
- 37:58Speaker 1: new market, what's the biggest friction in terms of building
- 38:02Speaker 1: out that that presence or franchise is it is it
- 38:05Speaker 1: the waber or are the care coordinators you know where
- 38:09Speaker 1: where where is it the hardest to build the next center?
- 38:13Speaker 2: I mean the hardest actually is the payer relationship on
- 38:16Speaker 2: the front. Really yeah, it's establishing with the health plan
- 38:22Speaker 2: the right way to to get paid, incentivizing the things
- 38:26Speaker 2: we've been talking about, whole child, whole family value. Once
- 38:33Speaker 2: we get that in place, it's a pretty standard playbook.
- 38:36Speaker 2: We work with the plan on where do they have
- 38:38Speaker 2: members that are underserved, look at those markets. Hire this
- 38:43Speaker 2: kind of core group of talent, and that's gotten more
- 38:47Speaker 2: and more replicable. And we found that physicians and nurse
- 38:50Speaker 2: practitioners have an interest in this area like being part
- 38:54Speaker 2: of a broader faculty. We have about thirty five medical
- 38:59Speaker 2: faculty and get to bounce ideas off each other. They're
- 39:02Speaker 2: really part of integrated care team. Each physician or NP
- 39:06Speaker 2: also gets to you know, they're the quarterback of their
- 39:08Speaker 2: center around overseeing anywhere from one hundred to three hundred
- 39:12Speaker 2: clinicians of different specialties to take care of their uh
- 39:17Speaker 2: their patients post referral. So hiring has not been a
- 39:22Speaker 2: huge hurdle. It's something that that you know comes in
- 39:26Speaker 2: a matter of months. In real estate, the build out
- 39:30Speaker 2: of custom centers we've developed a playbook for We've looked
- 39:34Speaker 2: at other companies that have done this well, like Oak
- 39:36Speaker 2: Street Health part of the CVS portfolio, CBS investor of
- 39:40Speaker 2: ours also so looked at like how do they build
- 39:43Speaker 2: out these these facilities that have really appealing layout and
- 39:50Speaker 2: footprint for children and families or inviting also have all
- 39:54Speaker 2: the requirements of of gym equipment that bolts into the
- 39:58Speaker 2: ceiling and outdoor place space. And we have a playbook
- 40:02Speaker 2: at this point to find space and build it out.
- 40:04Speaker 2: It does take some time, i'd say, from the from
- 40:07Speaker 2: the moment we say hey, we want to be in
- 40:08Speaker 2: a state and the payers have agreed, takes about six
- 40:12Speaker 2: to nine months to get the full team and the
- 40:15Speaker 2: site assembled. But at this point has become a fairly
- 40:20Speaker 2: kind of tried and true playbook on how to how
- 40:22Speaker 2: to stand them up.
- 40:24Speaker 1: You know, going back to that friction with payers, you know,
- 40:26Speaker 1: what do they misunderstand about the category? And I guess what?
- 40:30Speaker 1: And I'm sure this varies depending on who it is,
- 40:32Speaker 1: but what resonates with them that maybe gets them across
- 40:36Speaker 1: that that hurdle is it the total cost of care?
- 40:39Speaker 1: Is it fewer visits, you know, lower medication usage. You
- 40:42Speaker 1: know what seems to really resonate with them.
- 40:45Speaker 2: Yeah, And I wouldn't blanket all pairs with with statement
- 40:51Speaker 2: is I mean some are exceptionally and many are exceptionally good,
- 40:55Speaker 2: and they're incredibly great people at plans who really understand
- 40:59Speaker 2: the problem and are wonderful to work with. We have
- 41:01Speaker 2: several payers on our cap table six and then even
- 41:07Speaker 2: beyond that, we have many that we worked probably another
- 41:10Speaker 2: ten to twelve or so. We're absolutely wonderful to work with.
- 41:13Speaker 2: And what do they see. I'd say it's two things. One,
- 41:19Speaker 2: they see a member experience that is fragmented and challenging,
- 41:23Speaker 2: and the best payers now believe they exist to make
- 41:29Speaker 2: that better. They believe deeply in improving the customer experience.
- 41:33Speaker 2: I mean one I'll call out just because they mentioned
- 41:35Speaker 2: this at their investor day and then made this a
- 41:39Speaker 2: highlight as they approach their plan sponsors is CBS Etna.
- 41:45Speaker 2: At their investor day in December, their COO used time
- 41:50Speaker 2: in a relatively short allocated window to talk specifically about
- 41:53Speaker 2: acciden care and making it better and coordinating it and
- 41:57Speaker 2: recognize the friction. And they also speak a lot about
- 42:00Speaker 2: about just overall their role in healthcare is to make
- 42:03Speaker 2: the customer experience and navigation better. And so there are
- 42:08Speaker 2: many other plans who similarly have this ethos of you know,
- 42:12Speaker 2: we've got to get better at improving how consumers access
- 42:18Speaker 2: the healthcare system. And so this is a very clear
- 42:21Speaker 2: area where it's broken and needs to get better. And
- 42:25Speaker 2: the other is around cost and they look at three
- 42:29Speaker 2: buckets of spend and autism and some of this is
- 42:32Speaker 2: our education with them, but a lot of faumnists themselves.
- 42:35Speaker 2: And one is ABA regalization. Our average is nine to
- 42:38Speaker 2: ten hours a week. A lot of them are seeing
- 42:41Speaker 2: providers at thirty five hours a week, so they're seeing
- 42:44Speaker 2: like huge opportunity there. It's a big multiple four x.
- 42:49Speaker 2: Another is around admissions that particularly for moderate and severe phenotypes.
- 42:54Speaker 2: As those children age, the parents can struggle with having
- 42:59Speaker 2: the child at help. They're self injurious, hert others, the
- 43:05Speaker 2: furniture around, and so a family will feel like, hey,
- 43:07Speaker 2: this is overwhelming, show up in the ED. Then get
- 43:10Speaker 2: admitted to a residential facility. And with a coordinating care model,
- 43:15Speaker 2: we've shown that we can reduce admissions by a factor
- 43:17Speaker 2: of ten x. It's not a high percentage on an
- 43:19Speaker 2: absolute basis, it's maybe one to three percent of children
- 43:22Speaker 2: with autism get admitted in a year, but we're finding
- 43:25Speaker 2: point one percent in our population. And then the third
- 43:30Speaker 2: is the cost of academics medical centers, which continues to
- 43:34Speaker 2: kind of go up because they're very expensive. That a
- 43:36Speaker 2: lot of negotiating leverage, and that's where most of the
- 43:38Speaker 2: specialty care is today. So if a child is trying
- 43:41Speaker 2: to get a specialty neurology care, sleepcare, gi genetics inside
- 43:46Speaker 2: of great institutions Boston Children's Hospital, Duke UCLA, they're very,
- 43:51Speaker 2: very expensive and so being able to find alternative sites
- 43:56Speaker 2: of service to that. But you take those factors together
- 44:00Speaker 2: with our model, we can show fifty sixty percent savings
- 44:04Speaker 2: on a permember per year basis, and that's a driver
- 44:07Speaker 2: for them to work with us.
- 44:09Speaker 1: Maybe just thinking about your model a little bit more,
- 44:11Speaker 1: and I'll put my analyst hat back on. You know,
- 44:14Speaker 1: where's the leverage in the business model? And I guess
- 44:17Speaker 1: you know from a CEO perspective, what internal KPIs are
- 44:20Speaker 1: you most focused on day to day managing your growth
- 44:24Speaker 1: and the business as a whole.
- 44:26Speaker 2: Yeah, we focus on site sustainability, So there's a target
- 44:32Speaker 2: called it contribution margin. So the contribution of each site
- 44:37Speaker 2: there's a very reasonable level. I mean we think that
- 44:40Speaker 2: if you get too high there, then you're compromising on something.
- 44:44Speaker 2: You're either getting paid too much from your health plans
- 44:46Speaker 2: and that will come back at some point, or you're
- 44:51Speaker 2: overworking your clinical team and they will burn out and leave.
- 44:54Speaker 2: But there's a sweet spot which is a very healthy
- 44:57Speaker 2: contribution margin of each center that we that we strive
- 45:02Speaker 2: for and then the that the other is our corporate
- 45:06Speaker 2: overhead UH and we want to make sure that the
- 45:08Speaker 2: aggregate contribution margin across all of our centers will end
- 45:12Speaker 2: this year around close to twenty nine centers or so,
- 45:14Speaker 2: you know, the contribution margin from all of those in
- 45:16Speaker 2: aggregate more than offsets are our corporate spend. In the
- 45:20Speaker 2: early days, we spent a lot. We're building a lot
- 45:23Speaker 2: of tech, a lot of people oriented uh UH infrastructure,
- 45:29Speaker 2: a lot of FP and a but with with AI
- 45:33Speaker 2: and and good use of AI from everything from scheduling
- 45:36Speaker 2: to revenue cycle management, which is how we interface with
- 45:38Speaker 2: payers for aths and going, how we do development itself,
- 45:43Speaker 2: how we analyze our clinical data and provide clinical insights
- 45:46Speaker 2: back to our clinicians. A lot of that that used
- 45:49Speaker 2: to be manual is now AI first, and it's been
- 45:52Speaker 2: able to really reduce our corporate footprint and overhead. And
- 45:57Speaker 2: so those are the metrics we look at a lot,
- 46:00Speaker 2: the aggregate sort of contribution margin and the corporate spend
- 46:03Speaker 2: and making sure that you know, we're we're on track
- 46:06Speaker 2: to UH to self sustainability profitability very soon.
- 46:11Speaker 1: So maybe two questions, and I think these dovetailed together.
- 46:13Speaker 1: You know, as we think about data and personalization and
- 46:17Speaker 1: the rise of AI, how's that going to look different
- 46:20Speaker 1: in five years? And I guess the corollary to that is,
- 46:24Speaker 1: you know, what's gonna what's Cordica going to look like
- 46:26Speaker 1: in five years? What's going to surprise us about your success?
- 46:29Speaker 1: And the next couple a couple of years here, I
- 46:33Speaker 1: think that you know.
- 46:34Speaker 2: The piece that I'm most There are a few sort
- 46:36Speaker 2: of applications. One is, if I put into three, it's
- 46:39Speaker 2: a there's administrative, there's clinical workflows, and then clinical insights.
- 46:43Speaker 2: And it's the third bucket that's kind of the most
- 46:45Speaker 2: most cool administrative workflows we're actively using today.
- 46:49Speaker 1: And I think sure everybody across the provider landscape is.
- 46:53Speaker 2: Yeah, exactly from from scheduling, to how we do insurance
- 46:58Speaker 2: interfaces uh, et cetera. On the on the clinical workflows
- 47:02Speaker 2: we started to adopt, though I think still in early
- 47:05Speaker 2: innings of ambient AI, we use allow with their physicians
- 47:09Speaker 2: on how does ambient AI record a conversation or witness
- 47:14Speaker 2: a conversation between a family and a physician uh, and
- 47:17Speaker 2: then take all of that data put it into a
- 47:19Speaker 2: note and an action plan. It's a little harder, actually,
- 47:23Speaker 2: it's a lot harder when you've got a therapist working
- 47:26Speaker 2: with a child in a gym and there are other
- 47:28Speaker 2: kids around, and that kind of ambient AI recording is
- 47:31Speaker 2: something we haven't done as much of yet, but I
- 47:33Speaker 2: think are you looking forward to to getting into There's
- 47:36Speaker 2: some vendors doing some work in that area too, But
- 47:40Speaker 2: the one that I'm most intrigued about is the clinical
- 47:44Speaker 2: insights that we can gather and use them to phenotype
- 47:49Speaker 2: and determine the appropriate care plan for each child. So
- 47:53Speaker 2: right now, the physician is kind of the main overseer
- 47:56Speaker 2: of care or nurse practitioner is receiving so much information.
- 48:00Speaker 2: There's like lab data, genetic data and EEG which run.
- 48:04Speaker 2: There's history from the parents, there are real time updates
- 48:07Speaker 2: from the parents, clinician, input from the behavioral team, the
- 48:11Speaker 2: speech TMOT team, et cetera, the school system, and they're
- 48:15Speaker 2: they're synthesizing all of this and in their mind kind
- 48:18Speaker 2: of categorizing each child into a phenotype. And they're very big,
- 48:24Speaker 2: standardized phenotypes that are in the d s M five
- 48:27Speaker 2: level one, two, three of autism, but they're much more
- 48:30Speaker 2: refined phenotypes. Like all clinicians will have kind of probably
- 48:33Speaker 2: one of dozens of buckets, they put a child in
- 48:35Speaker 2: two and say, okay, based on this, this is the
- 48:37Speaker 2: right therapy for this child right now. And the future
- 48:42Speaker 2: is having all that data in one place and using
- 48:48Speaker 2: tech uh to understand what is the phenotype of that
- 48:52Speaker 2: child at that time and therefore what are the optimal
- 48:55Speaker 2: set of therapies. And it's a real personalization, personalized medicine
- 49:00Speaker 2: of autism that we have in many other fields of
- 49:03Speaker 2: medicine and that we'll be here very soon. What you
- 49:07Speaker 2: need to pull this off is access to all that data,
- 49:12Speaker 2: and you need access to a broad care team. So
- 49:14Speaker 2: if the action is more on the medical side, you
- 49:16Speaker 2: can implement that. If it's a specific type of behavioral intervention,
- 49:21Speaker 2: you've got that. If it's OT and fine motor skills,
- 49:26Speaker 2: you know, that's in your toolkit. But the future of
- 49:28Speaker 2: using AI to personalize care and know and what are
- 49:33Speaker 2: the triggers that are causing certain behaviors and how can
- 49:37Speaker 2: you modify those That's that's really the future. Because it's
- 49:41Speaker 2: such a data rich field. I struggle sort of thinking
- 49:45Speaker 2: about other fields of medicine that have so much data
- 49:49Speaker 2: to bring to bear in a treatment plan. I mean,
- 49:52Speaker 2: ecology is very data rich, but it's a codified set
- 49:56Speaker 2: of data. Like you've got a lot of gene expression
- 50:00Speaker 2: imaging data, but it all can sorted, be put in
- 50:02Speaker 2: one place and you know, analyzed. This is such a
- 50:08Speaker 2: broader range of data that's environmental factors and so many things.
- 50:12Speaker 2: It kind of boggles the mind on how much would
- 50:16Speaker 2: need to be analyzed to construct these phenotypes and optimal
- 50:19Speaker 2: developmental trajectories.
- 50:21Speaker 1: It's really well said. I don't think I appreciated how
- 50:23Speaker 1: multi modal your data is in this in this space,
- 50:28Speaker 1: you know, relative to like something like oncology or cardio.
- 50:31Speaker 1: That's that sort of thing. That was a great explanation.
- 50:33Speaker 2: Thank you, Yeah, thanks. It's something that from the very beginning,
- 50:37Speaker 2: we put a lot of emphasis in is creating a
- 50:42Speaker 2: data warehouse. We had an early pilot with health Lake,
- 50:45Speaker 2: which is an AWMSIS product. Yeah, exactly, so we were
- 50:50Speaker 2: There was a white paper we put together with them
- 50:51Speaker 2: in twenty twenty one where I mean from our inception
- 50:55Speaker 2: we knew we were sitting on this an incredibly valuable
- 50:58Speaker 2: data set, and we have built it to now be
- 51:00Speaker 2: thirty thousand patients spanning everything from their genetic sequencing to
- 51:06Speaker 2: years and years of behavioral outcomes data what meds were
- 51:09Speaker 2: they on with their loud show? And it shows some
- 51:12Speaker 2: really cool correlations, But to date those have been largely
- 51:16Speaker 2: you know, our biostatistical team going in asking a question
- 51:20Speaker 2: with a physician like, hey, did this particular you know,
- 51:23Speaker 2: genetic polymorphism, how did it correlate with outcomes over multiple years?
- 51:27Speaker 2: They ask a question standard research, Now you can tap
- 51:33Speaker 2: AI into this and how to draw all sorts of
- 51:36Speaker 2: hypotheses from such a massive data set. So that's the
- 51:41Speaker 2: future that I'm really excited about.
- 51:44Speaker 1: That's very well said, and I'm excited to see that
- 51:46Speaker 1: future as well. Maybe just to wrap it up here,
- 51:49Speaker 1: one of the ways I like to end these discussions
- 51:51Speaker 1: is to ask the guest about something for either their
- 51:53Speaker 1: personal or professional life that they see as I don't know,
- 51:56Speaker 1: a guiding a guiding force, and what they see as
- 51:59Speaker 1: their mission. And is there something that comes to mind, Neil,
- 52:01Speaker 1: that that you see as maybe guiding what you and
- 52:04Speaker 1: Czan s as your your mission in life.
- 52:06Speaker 2: Yeah, I really appreciate that question. So I think in
- 52:10Speaker 2: both of our families, we came from immigrant families, there
- 52:14Speaker 2: was this ethos of be useful, which I thought was
- 52:18Speaker 2: really interesting because when Schwarzeger put out his autobiography was
- 52:23Speaker 2: titled with with that ours were in our respective languages.
- 52:28Speaker 2: I grew up in an Indian household, my wife in
- 52:30Speaker 2: a Chinese one, but there was very much this ethos
- 52:33Speaker 2: of like we were fortunate around sort of the academic
- 52:38Speaker 2: exposures we had. We were fortunate for a lot of
- 52:41Speaker 2: education was paid for with scholarships and things. So there
- 52:44Speaker 2: was this real desire by my grandfather, who I got
- 52:50Speaker 2: to be very close with, and my parents and my
- 52:53Speaker 2: wife's folks on you use this to be useful to
- 52:57Speaker 2: the world as opposed to just useful to yourself. So
- 53:01Speaker 2: it's a lot of what what drives us and Uh,
- 53:05Speaker 2: you know, I feel like we're fortunate to have found
- 53:07Speaker 2: an area of medicine where we can be really impactful
- 53:11Speaker 2: that really needs it, and we've attracted an incredibly cool
- 53:16Speaker 2: team around us that's really driven by by the same purpose,
- 53:20Speaker 2: including I think a very cool investor syndicate. We have
- 53:26Speaker 2: growth and venture investors, and some really cool strategic investors
- 53:30Speaker 2: who are health plans, nonprofit health systems, parent groups who
- 53:36Speaker 2: are very motivated to change the field. And so yeah,
- 53:39Speaker 2: it's really I think what I'm what I'm driven by
- 53:43Speaker 2: is just this this hope to be impactful to parents
- 53:47Speaker 2: who could use it.
- 53:49Speaker 1: Well, I think you guys are doing a great job
- 53:51Speaker 1: and I can't wait to see where you guys go next.
- 53:53Speaker 1: Thank you so much for sharing that.
- 53:55Speaker 2: Oh thank you, Jonathan, really appreciate the opportunity here and
- 53:59Speaker 2: fantastic set a quot us. Thank you.
- 54:01Speaker 1: Yeah, we'll have to have you on a couple of
- 54:02Speaker 1: years see where you are. That's doctor Neil Hattengotti, CEO
- 54:06Speaker 1: and co founder of Cordica. Thank you so much for
- 54:09Speaker 1: joining us for our latest episode, and please make sure
- 54:11Speaker 1: to click the follow button on your favorite podcast app
- 54:14Speaker 1: or website so you never miss a future discussion with
- 54:17Speaker 1: the leaders in healthcare innovation. I'm Jonathan Palmer, and you've
- 54:20Speaker 1: been listening to the Vanguards of Healthcare podcast by Bloomberg Intelligence.
- 54:23Speaker 1: Until next time, take care,